SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEART
Autor: | Rosén, Hans Christian, Mohammad, Moman A., Jernberg, Tomas, James, Stefan, Oldgren, Jonas, Erlinge, David |
---|---|
Zdroj: | In The Lancet Regional Health - Europe October 2024 45 |
Databáze: | ScienceDirect |
Externí odkaz: |